Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants.
Antib Ther. 2022 May 12;5(2):130-137. doi: 10.1093/abt/tbac011. eCollection 2022 Apr.
Antib Ther. 2022.
PMID: 35769631
Free PMC article.